Children's Health

Main Content

Children's Health Studies

Does your child have health issues? Do you know someone who has similar health interests or issues? UMMC is conducting clinical research studies to look at potential treatments, medications and other children's health-related protocols. If you would like to know more about our efforts, you can visit the links below.

  • This study, referred to as Venous Thromoembolic Event, will assess an experimental drug in children requiring anticoagulation for the treatment of venous thromboembolic event. Click here for details.
  • This study, referred to as AALL1621, is looking at the effects of an experimental drug in pediatric patients with relapsed leukemia. Click here for details.
  • This study, referred to as A LTE15N2, is looking at lab test results and radiology test results to evaluate for long-term effects of high-risk neuroblastoma treatment. Click here for details.
  • The goal of this study, referred to as KIDCARE, is to determine the effects of an experimental drug in IVIG-resistant Kawasaki Disease (KD) patients. Click here for details.
  • The study, referred to as PBMTC, is evaluating the use of next generation sequencing in improving the diagnosis of lower respiratory tract infections in pediatric stem cell transplant patients. Click here for details.
  • This study, referred to as Adolescents Type 2 Diabetes, seeks to evaluate the effect of an experimental drug in children and adolescents with type 2 diabetes mellitus. Click here for details.
  • This study, referred to as ALPINE 2, is evaluating an experimental drug in patients with cystic fibrosis and new onset respiratory tract Pseudomonas Aeruginosa infection. Click here for details.
  • This study, referred to as fliGHt, will assess safety and tolerability of an experimental drug in children with growth hormone deficiency (GHD). Click here for details.
  • This study, referred to as ADRENL Study, is looking at the efficacy of a drug for treatment of steroid-resistant nephrotic syndrome in the pediatric population. Click here for details.
  • This study, referred to as Hectoral Study, is evaluating the possible risks and effectiveness of an experimental drug in patients with secondary hyperparathyroidism not yet on dialysis. Click here for details.
  • This study, referred to as Pediatric MATCH, is to match participants to targeted experimental drugs based on molecular changes found in their tumor samples. Click here for details.
  • This study, referred to as HEART Study, is looking at whether previous cancer patients who received dexrazoxane have better heart function than those who didn't receive dexrazoxane. Click here for details.
  • This study, referred to as enligGHten Study, is looking to assess long-term safety and efficacy of an experimental drug in children with GHD previously treated in a phase 3 experimental drug trial. Click here for details.
  • A study, referred to as L-citrulline Study, is looking at a way to decrease the incidents of respiratory sequelae associated with cardio-pulmonary bypass during corrective surgery. Click here for details.